The U.S. Food and Drug Administration (FDA) has granted fast-track designation to CK0803, an experimental T-cell therapy from Cellenkos that’s currently in Phase 1 clinical testing for people with ...

H.C. Wainwright initiated coverage on Virax Biolabs Group Limited (NASDAQ:VRAX), a U.K.-based company focused on detecting immune responses and diagnosing viral diseases. Virax Biolabs is developing T ...

Researchers at MIT have found a way to use a nontoxic antifreeze sugar to protect CAR-T cells from damage during storage and ...

Providing vital health care services to people in developing countries without reliable electricity, refrigeration and state-of-the-art medical equipment poses a number of challenges. Inspired by ...

A blood test following CAR T-cell therapy for relapsed/refractory mantle cell lymphoma (MCL) appears to do a better job than PET-CT scans at predicting which patients have poor prognoses, a small, ...

Immunotherapy has transformed cancer treatment, but persistent challenges, such as T cell exhaustion, limited persistence, and variability in response, continue to impact therapeutic success.